Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

05 August 2020: Clinical Research

Exosomes Mediated Transfer of Circ_UBE2D2 Enhances the Resistance of Breast Cancer to Tamoxifen by Binding to MiR-200a-3p

Ke Hu BCD , Xianhao Liu BCD , Yi Li ABC , Qinyang Li DEF , Yijun Xu DEF , Wei Zeng DEF , Guocheng Zhong CDEF , Changhua Yu CDE*

DOI: 10.12659/MSM.922253

Med Sci Monit 2020; 26:e922253

Figure 2 Circ_UBE2D2 deletion mitigates tamoxifen resistance in tamoxifen-resistant breast cancer cells. (A, B) qRT-PCR analysis on the expression of circ_UBE2D2 in tamoxifen-resistant and tamoxifen-sensitive breast cancer patients, as well as in parent and resistant breast cancer cells was conducted. MCF-7/TAM-R and T47D/TAM-R cells were transfected with si-circ_UBE2D2 or si-NC. (C) The expression of circ_UBE2D2 in MCF-7/TAM-R and T47D/TAM-R cells was examined using qRT-PCR to analyze the interference efficiency. (D) The viability and IC50 values of MCF-7/TAM-R and T47D/TAM-R cells treated with different concentrations of tamoxifen were detected by CCK-8 assay. (E, F) The migration and invasion analysis of parental and resistant cells treated with 20 μM tamoxifen was performed using Transwell assay. (G) The levels of ERα, vimentin, and E-cad in parent and resistant cells treated with 20 μM tamoxifen were detected using western blot. * P<0.05, ** P<0.01. qRT-PCR – real-time polymerase chain reaction; CCK-8 – Cell Counting Kit-8; ERα – estrogen receptor alpha; E-cad – E-cadherin.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750